Actinic keratosis
Also known as: Solar keratosis, Senile keratosis, Actinic keratoses, Solar keratoses
Actinic keratosis represents a ultraviolet-induced cutaneous dysplasia characterised by keratinocyte atypia. Presenting typically as hyperkeratotic, erythematous plaques on sun-exposed anatomical sites, the condition exists on a continuous biological spectrum with cutaneous squamous cell carcinoma. Due to the potential for malignant transformation, formal medical diagnosis and longitudinal surveillance are mandatory. Primary management is conducted by general practitioners or dermatologists via field-directed therapies or targeted lesion ablation. Traditional Chinese Medicine may serve an adjunctive role in addressing constitutional well-being or comorbid symptoms, but it must not substitute for clinical diagnosis, histopathological examination, or conventional medical intervention. Current clinical literature provides no empirical evidence demonstrating that acupuncture or herbal pharmacology can resolve these lesions or provide prophylaxis against cutaneous malignancy. The diagnostic and genomic data cited herein do not substantiate therapeutic efficacy for the condition. The documented patterns represent traditional frameworks for constitutional assessment and do not constitute validated clinical subtypes of actinic keratosis.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Apply broad-spectrum SPF 50+ sunscreen, utilise protective clothing and broad-brimmed headwear, prioritise shade, and avoid deliberate tanning.
- •Strictly adhere to dermatological instructions regarding therapeutic interventions and post-treatment care, including specific directives concerning cosmeceuticals and ultraviolet exposure.
- •Refrain from mechanical debridement or excoriation of lesions and avoid the application of caustic home remedies; utilise only gentle, non-sensitising emollients on the perilesional integument.
- •Maintain attendance at all scheduled dermatological examinations and document new or evolving lesions using dated clinical photography for practitioner review.
Cautions & Contraindications
- •Do not needle, bleed, heat with moxa, scrape or cup an actinic keratosis, suspicious lesion, biopsy site or inflamed treatment field. This is a precaution to avoid injury and diagnostic delay, not a procedure-specific conclusion tested in the supplied study.[]
- •Do not use a TCM pattern diagnosis or apparent symptom improvement to defer biopsy, prescribed lesion treatment or cancer surveillance. The supplied diagnostic study describes overlap with squamous cell carcinoma and does not validate complementary alternatives.[]
When to reassess or seek care again
Review any adjunctive symptom-care trial after 2–4 weeks, documenting itch or dryness on a 0–10 scale, sleep disruption, distress, adverse effects and adherence to medical care. Stop or revise adjunctive care if there is no meaningful symptom improvement. Lesion response and surveillance intervals remain dermatologist-led; any rapid growth, bleeding, ulceration, new firmness or persistent pain triggers prompt medical review without waiting for the scheduled reassessment.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Photodiagnosis and photodynamic therapy · 2026
- Photodiagnosis and photodynamic therapy · 2026
- Clinical, cosmetic and investigational dermatology · 2025
- Frontiers in immunology · 2026
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
